Tokyo Tape
Sign in
← Tohoku Chemical

Quarterly report · Q1

7446.TEDINET S100ST6L
Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥8.3bn2023-10-01 → 2023-12-31Cons.Net sales
Revenue¥35.1bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥9.4bn2022-10-01 → 2022-12-31Cons.Net sales
Operating income¥58m2023-10-01 → 2023-12-31Cons.Operating income
Operating income¥254m2022-10-01 → 2022-12-31Cons.Operating income
Ordinary income¥78m2023-10-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥808m2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥271m2022-10-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥90m2023-10-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥271m2022-10-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥53m2023-10-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥556m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥182m2022-10-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥53m2023-10-01 → 2023-12-31Cons.Profit loss
Net income¥187m2022-10-01 → 2022-12-31Cons.Profit loss
Total assets¥19.7bnat 2023-12-31Cons.Assets
Total assets¥18.9bnat 2023-09-30Cons.Assets
Total assets¥19.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥12.4bnat 2023-12-31Cons.Liabilities
Total liabilities¥11.7bnat 2023-09-30Cons.Liabilities
Net assets / equity¥7.3bnat 2023-12-31Cons.Net assets
Net assets / equity¥7.3bnat 2023-09-30Cons.Net assets
Net assets / equity¥6.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.3bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥2.2bnat 2023-09-30Cons.Cash and deposits
EPS (basic)¥59.342023-10-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥617.292022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥202.312022-10-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio36.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue2023-10-01 → 2023-12-31¥518m
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue external2023-10-01 → 2023-12-31¥518m
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue2023-10-01 → 2023-12-31¥4.2bn
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue external2023-10-01 → 2023-12-31¥4.2bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue2023-10-01 → 2023-12-31¥3.6bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue external2023-10-01 → 2023-12-31¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2023-12-31¥8.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2023-12-31¥8.3bn
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue2022-10-01 → 2022-12-31¥552m
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue external2022-10-01 → 2022-12-31¥552m
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue2022-10-01 → 2022-12-31¥4.6bn
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue external2022-10-01 → 2022-12-31¥4.6bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue2022-10-01 → 2022-12-31¥4.3bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue external2022-10-01 → 2022-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2022-12-31¥9.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2022-12-31¥9.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 365
ItemContextValueUnit
Gross profitPrior1YTDDuration_ReconcilingItemsMember－JPY
Gross profitPrior1YTDDuration869460000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02810-000IndustrySalesGroupReportableSegmentMember4175117000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02810-000MedicalSalesGroupReportableSegmentMember3637008000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02810-000AcademiaLifeScienceSalesGroupReportableSegmentMember518159000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember8330285000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration8330285000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E02810-000IndustrySalesGroupReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E02810-000MedicalSalesGroupReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E02810-000AcademiaLifeScienceSalesGroupReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E02810-000IndustrySalesGroupReportableSegmentMember4175117000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E02810-000MedicalSalesGroupReportableSegmentMember3637008000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E02810-000AcademiaLifeScienceSalesGroupReportableSegmentMember518159000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember8330285000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration8330285000JPY
Gross profitCurrentYTDDuration_jpcrp040300-q1r_E02810-000IndustrySalesGroupReportableSegmentMember420585000JPY
Gross profitCurrentYTDDuration_jpcrp040300-q1r_E02810-000MedicalSalesGroupReportableSegmentMember293452000JPY
Gross profitCurrentYTDDuration_jpcrp040300-q1r_E02810-000AcademiaLifeScienceSalesGroupReportableSegmentMember46061000JPY
Gross profitCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember760098000JPY
Gross profitCurrentYTDDuration_ReconcilingItemsMember－JPY
Gross profitCurrentYTDDuration760098000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)東北財務局長
Filing date cover pageFilingDateInstant2024-02-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第73期第１四半期(自 2023年10月１日 至 2023年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)東北化学薬品株式会社
Company name in english cover pageFilingDateInstantTOHOKU CHEMICAL CO., LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　東　康之
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)青森県弘前市大字神田一丁目３番地の１
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)0172　(33)　8131　　　　(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員管理グループ総務部長　相馬　俊一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)青森県弘前市大字神田一丁目３番地の１
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)0172　(33)　8131　　　　(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員管理グループ総務部長　相馬　俊一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE02810
Fund codeFilingDateInstant－
Security codeFilingDateInstant74460
Filer name in japaneseFilingDateInstant
Original text (Japanese)東北化学薬品株式会社
Filer name in englishFilingDateInstantTOHOKU CHEMICAL CO.,LTD.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-09-30pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass